Dogwood Therapeutics, Inc DWTX
1.36
(0.07)
(4.90%)
as of 25 Sep
- Market cap
- $48.6M
- P/E
- 0.0×
Follow DWTX
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Current Ratio |
3.89 | 5.86 | 2.76 | 4.49 |
+8 more quarters Free account |
Net Debt/EBITDA |
0.68 | 2.61 | 1.71 | 0.64 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.31 | 0.92 | 0.96 | 0.21 | |
Capex/Depreciation |
— | — | 0.00 | 0.00 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.86 | 0.84 | 0.90 | 0.87 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow per Share |
(0.11) | (0.14) | (0.73) | (1.71) | |
Cash per Share |
0.28 | 0.39 | 1.31 | 5.28 | |
Shareholders Equity per Share |
2.00 | 2.40 | 15.05 | 40.33 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
2.00 | 2.40 | 15.05 | 40.33 | |
Free Cash Flow |
(3.61) | (4.59) | (3.64) | (3.27) | |
Working Capital |
8.19 | 12.44 | 5.37 | 9.06 | |
Net Current Asset Value |
(1.10) | 0.42 | (6.84) | (2.95) | |
| Other line items | |||||
Quick Ratio |
3.39 | 5.17 | 2.13 | 3.90 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.11) | (0.14) | (0.73) | (1.71) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Payables |
0.45 | 0.65 | 1.00 | 0.52 | |
Average Assets |
88.59 | 96.10 | 92.24 | 47.14 | |
Average Common Equity |
25.13 | 31.36 | 32.39 | (16.06) | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates